Read more about our research in the journal Clinical Gastroenterology and Hepatology: https://bit.ly/4eA8qIP #BMS_Employee | 11 comments on LinkedIn #bms_employee | Daniel Quirk, MD, MPH, MBA | 11 ...

Camie’s quirk “Glamour” is arguably one of the strongest powers in terms of utility and support. Despite her few appearances in My Hero Academia, Camie’s quirk has managed to shine through ...

Oklahoma City adds another big body to its frontline by trading for Pelicans center Daniel Theis. Associated Press Veteran center Daniel Theis is averaging 4.3 points and 4.3 rebounds per game ...

As the major cost-cutting initiative at Bristol Myers Squibb rolls on, the company has launched another round of layoffs in its home state of New Jersey. BMS’ latest workforce reduction affects ...

The Minnesota Vikings did not sign Daniel Jones midway through the 2024 season for him to ride the bench behind Sam Darnold; they saw the move as a de facto job shadow for the 2025 season.

Daniel Khalife, 23, had sparked a nationwide manhunt after clinging to the underside of lorry to break out of jail in September last year. He was on the run for three days, when he was found ...

With another trial win, Bristol Myers Squibb is touting Breyanzi as the CD19-directed CAR-T therapy with positive readouts in the most cancer types. The latest readout positions Breyanzi for a ...

Daniel Khalife, 23, sparked a nationwide manhunt after clinging to the underside of a food delivery lorry to break out of the Category B jail on 6 September last year. He evaded capture for three ...

Daniel Jones and Saquon Barkley shared a close bond during their time with the Giants, and it seems that hasn’t changed despite the two no longer being teammates. Jones was on hand on Sunday ...

The Minnesota Vikings‘ quarterback future may center around J.J. McCarthy and Sam Darnold — but Daniel Jones could play a crucial factor in the team’s decision. In his end-of-season news ...

The quarter's results, reaffirmed Bristol Myers Squibb's financial health and strategic focus despite ongoing competition from generics manufacturers impacting its legacy portfolio of drugs.